Ya-Ling Han

Showing 1-7 of 7 articles

Coronary interventions

Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial

Zhang Y-J, Wang X-Z, Fu G, Jing Q, Wang G, Jin C-Y, Xie L-H, Cai J-Z, Xu B, Han Y-L

November 20, 2016 | 10.4244/EIJV12I10A209

Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study

Xu B, Yang Y, Han Y-L, Lu S-Z, Li B, Liu Q, Zhu G-Y, Cui J-Y, Li L, Zhao Y-L, Kirtane A

May 20, 2014 | 10.4244/EIJV10I1A12

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y-L, Zhong S-L

September 27, 2013 | 10.4244/EIJV9I5A90

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y-L, Zhang X-L, Li Y, Yan C-H, Kang J

July 26, 2013 | 10.4244/EIJV9I3A53

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study

Zhu X-Y, Qin Y, Han Y-L, Zhang D-Z, Wang P, Liu Y-F, Xu Y-W, Jing Q, Xu K, Gersh B, Wang X-Z

March 22, 2013 | 10.4244/EIJV8I11A195

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

Han Y-L, Zhang L, Yang L-X, Liu H-L, Qu P, Li W-M, Jiang T, Li S-M, Jing Q, Zhang Q-Y, Xu B, Li Y, Gao R

November 20, 2012 | 10.4244/EIJV8I7A124

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease